Search Results 191-200 of 1525 for 台湾搜索神器 🔍 www.29.gs
About this study. Primary Objective: Phase 1: To determine the maximum tolerated dose (MTD)/maximum administered dose (MAD) of SAR650984 (Isatuximab).
This multicenter, non-randomized, open-label study will evaluate the efficacy and safety of six treatment regimens in participants with advanced solid tumors ...
... 29:10-06:00</lastmod><xhtml:link rel="alternate" hreflang="ar" href="https://www.mayoclinic.org/ar/diseases-conditions/epilepsy/diagnosis-treatment/drc ...
placebo in patients with hereditary hemorrhagic telangiectasia (HHT) with moderate-to-severe epistaxis who require parenteral iron infusions or blood ...
The purpose of this study is to evaluate the effectiveness of LY3314814 in the treatment of people who have mild Alzheimer's disease dementia. Participation ...
The purpose of this study is to collect and correlate the data from various cardiovascular risk asessments to successfully measure the risk of heart toxicity in ...
Drugs and Supplements. Search prescription and over-the-counter drugs ...
About this study. The purpose of this research study is to find out what effects, good and/or bad, the drug regorafenib has on stomach or esophagus cancer ...
This study is being implemented to identify the role of prophylactic use of ethanol lock in adult patients on home parenteral nutrition (HPN). Central catheter ...
Search for a doctor. Ty S. Diwan, M.D.. Transplant Surgeon. Request an Appointment · Overview · Publications. Patient Stories. Print. PST-20507515.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.